Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 rpoB mutation conferring rifampin resistance in Streptococcus pyogenes.

Literature DB >> 11959602

rpoB mutation conferring rifampin resistance in Streptococcus pyogenes.

Hélène Aubry-Damon¹, Marc Galimand, Guy Gerbaud, Patrice Courvalin.

Abstract

Streptococcus pyogenes BM4478 and Staphylococcus aureus BM4479 were isolated from a patient undergoing rifampin therapy. High-level resistance to rifampin was due to the following mutations in the rpoB gene: Ser522Leu in strain BM4478 and His526Asn and Ser574Leu in strain BM4479.

Entities: Chemical Species

Mesh：

Substances：

Year: 2002 PMID： 11959602 PMCID： PMC127170 DOI： 10.1128/AAC.46.5.1571-1573.2002

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

12 in total

1. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus.

Authors: T A Wichelhaus; V Schäfer; V Brade; B Böddinghaus
Journal: Antimicrob Agents Chemother Date: 1999-11 Impact factor: 5.191

2. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.

Authors: H Taniguchi; H Aramaki; Y Nikaido; Y Mizuguchi; M Nakamura; T Koga; S Yoshida
Journal: FEMS Microbiol Lett Date: 1996-10-15 Impact factor: 2.742

3. Rifampin: mechanisms of action and resistance.

Authors: W Wehrli
Journal: Rev Infect Dis Date: 1983 Jul-Aug

4. Marker discrimination in transformation and mutation of pneumococcus.

Authors: J G Tiraby; M S Fox
Journal: Proc Natl Acad Sci U S A Date: 1973-12 Impact factor: 11.205

5. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

Authors: D J Jin; C A Gross
Journal: J Mol Biol Date: 1988-07-05 Impact factor: 5.469

6. Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase.

Authors: K Severinov; M Soushko; A Goldfarb; V Nikiforov
Journal: J Biol Chem Date: 1993-07-15 Impact factor: 5.157

7. Molecular characterization of rifampin-resistant Neisseria meningitidis.

Authors: P E Carter; F J Abadi; D E Yakubu; T H Pennington
Journal: Antimicrob Agents Chemother Date: 1994-06 Impact factor: 5.191

8. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci.

Authors: R R Tanz; S T Shulman; M J Barthel; C Willert; R Yogev
Journal: J Pediatr Date: 1985-06 Impact factor: 4.406

9. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.

Authors: H Aubry-Damon; C J Soussy; P Courvalin
Journal: Antimicrob Agents Chemother Date: 1998-10 Impact factor: 5.191

10. The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase.

Authors: K Severinov; A Mustaev; E Severinova; M Kozlov; S A Darst; A Goldfarb
Journal: J Biol Chem Date: 1995-12-08 Impact factor: 5.157

13 in total

1. rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin.

Authors: Wafa Achour; Olfa Guenni; Marguerite Fines; Roland Leclercq; Assia Ben Hassen
Journal: Antimicrob Agents Chemother Date: 2004-07 Impact factor: 5.191

2. New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.

Authors: María-José Ferrándiz; Carmen Ardanuy; Josefina Liñares; Luz Balsalobre; María Teresa García; Adela G de la Campa
Journal: Antimicrob Agents Chemother Date: 2010-11-01 Impact factor: 5.191

3. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.

Authors: David M Rothstein; Ronald S Farquhar; Klari Sirokman; Karen L Sondergaard; Charles Hazlett; Angelia A Doye; Judith K Gwathmey; Steve Mullin; John van Duzer; Christopher K Murphy
Journal: Antimicrob Agents Chemother Date: 2006-08-28 Impact factor: 5.191

4. Activity of novel benzoxazinorifamycins against rifamycin-resistant Streptococcus pyogenes.

Authors: Steve Mullin; David M Rothstein; Christopher K Murphy
Journal: Antimicrob Agents Chemother Date: 2006-05 Impact factor: 5.191

5. Highly rifampin-resistant Listeria monocytogenes isolated from a patient with prosthetic bone infection.

Authors: Viviane Chenal-Francisque; Caroline Charlier; Saleem Mehvish; Hélène Dieye; Alexandre Leclercq; Patrice Courvalin; Marc Lecuit
Journal: Antimicrob Agents Chemother Date: 2014-01-06 Impact factor: 5.191

6. Antimicrobial drug resistance affects broad changes in metabolomic phenotype in addition to secondary metabolism.

Authors: Dagmara K Derewacz; Cody R Goodwin; C Ruth McNees; John A McLean; Brian O Bachmann
Journal: Proc Natl Acad Sci U S A Date: 2013-01-22 Impact factor: 11.205

7. Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis.

Authors: Minsheng Xia; Robert J Suchland; Joli A Carswell; John Van Duzer; Debra K Buxton; Kara Brown; David M Rothstein; Walter E Stamm
Journal: Antimicrob Agents Chemother Date: 2005-09 Impact factor: 5.191

8. Role of DNA base excision repair in the mutability and virulence of Streptococcus mutans.

Authors: Kaisha Gonzalez; Roberta C Faustoferri; Robert G Quivey
Journal: Mol Microbiol Date: 2012-06-15 Impact factor: 3.501

9. Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.

Authors: Ute Dreses-Werringloer; Ingrid Padubrin; Lars Köhler; Alan P Hudson
Journal: Antimicrob Agents Chemother Date: 2003-07 Impact factor: 5.191

10. Developing a genetic system in Deinococcus radiodurans for analyzing mutations.

Authors: Mandy Kim; Erika Wolff; Tiffany Huang; Lilit Garibyan; Ashlee M Earl; John R Battista; Jeffrey H Miller
Journal: Genetics Date: 2004-02 Impact factor: 4.562